S
Sanjay Talole
Researcher at Homi Bhabha National Institute
Publications - 59
Citations - 1013
Sanjay Talole is an academic researcher from Homi Bhabha National Institute. The author has contributed to research in topics: Cancer & Radionuclide therapy. The author has an hindex of 18, co-authored 55 publications receiving 765 citations. Previous affiliations of Sanjay Talole include Tata Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Advanced squamous cell carcinoma of lower gingivobuccal complex: Patterns of spread and failure†
K. A. Pathak,Samir Gupta,Sanjay Talole,Vishal Khanna,Pankaj Chaturvedi,Mandar S. Deshpande,Prathamesh S. Pai,Devendra Chaukar,Anil K. D'Cruz +8 more
TL;DR: Carcinoma of the gingivobuccal complex is commonly associated with the use of smokeless tobacco known as “quid.”
Journal ArticleDOI
Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients
Suhail I. Sayed,Shilpi Sharma,P. Rane,Sagar Vaishampayan,Sanjay Talole,Pankaj Chaturvedi,Devendra Chaukar,Anuja Deshmukh,Jai Prakash Agarwal,Anil K. D'Cruz +9 more
TL;DR: To evaluate the prognostic role of the lymph node ratio (LNR; ratio of total positive nodes to total dissected nodes) in oral squamous cell carcinoma (OSCC) as compared to pN staging with an aim to provide an optimal cut‐off value.
Journal ArticleDOI
Evolution of pancreatoduodenectomy in a tertiary cancer center in India: improved results from service reconfiguration.
Shailesh V. Shrikhande,Savio G. Barreto,B.A. Somashekar,Kunal Suradkar,Guruprasad S. Shetty,Sanjay Talole,Bhawna Sirohi,Mahesh Goel,Parul J. Shukla +8 more
TL;DR: Evolution of practice and perioperative management of PD for pancreatic cancer at a tertiary cancer center in India improvedPerioperative outcomes and helped sustain the improvements despite increasing surgical volume, as well as reducing overall morbidity rates.
Journal ArticleDOI
Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
TL;DR: 177Lu-DOTATATE PRRT was found safe and well tolerated in receptor-positive pulmonary NETs with metastatic/advanced disease and the relationship between response, mortality, and overall survival with dual-tracer molecular imaging parameters was studied.
Journal ArticleDOI
Tobacco, alcohol and tea drinking as risk factors for esophageal cancer: A case-control study from Mumbai, India.
TL;DR: Among the beverages, tea drinking, common in India, showed a 4-fold excess risk for esophageal cancer, however fresh-fish showed a 20% reduction in risk, and a clear dose-response relationship in those with the habits.